Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Long-Term Growth and Skeletal Effects of Early Growth Hormone Treatment in Turner Syndrome

ClinicalTrials.gov ID: NCT00266656

Public ClinicalTrials.gov record NCT00266656. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 2:01 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Effect of Early Growth Hormone Treatment on Long-term Growth and Skeletal Maturation in Girls With Turner Syndrome

Study identification

NCT ID
NCT00266656
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
69 participants

Conditions and interventions

Interventions

  • Humatrope Drug

Drug

Eligibility (public fields only)

Age range
4 Years to 20 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2005
Primary completion
Aug 31, 2015
Completion
Aug 31, 2015
Last update posted
Mar 30, 2017

2005 – 2015

United States locations

U.S. sites
9
U.S. states
9
U.S. cities
9
Facility City State ZIP Site status
Childrens Hospital of Los Angeles Los Angeles California 90027
Children's Hospital Aurora Colorado 80045
Connecticut Children's Medical Center Hartford Connecticut 06106
Children's Hospital of Chicago Research Center Chicago Illinois 60611
Riley Hosptial for Children Indianapolis Indiana 46202
Children's Mercy Hospital Kansas City Missouri 64108
University of NC at Chapel Hill School of Medicine Chapel Hill North Carolina 27514
Thomas Jefferson University Philadelphia Pennsylvania 19107
Childrens Hospital and Medical Center Seattle Washington 98105

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00266656, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 30, 2017 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00266656 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →